Optimal Acuity Corporation


PhD, Harvard; BSc, Berkeley
Experience: Princeton University,
Princeton Neuroscience Institute
25+ Years Experience in Retinal Research

Michael J Berry II has over 25 years of experience at the forefront of vision and retina research. Michael is an Associate Professor of Princeton University and the Princeton Neuroscience Institute. He was Co-Director of the Program in Neuroscience at Princeton University and Methods in Computational Neuroscience at the Marine Biological Laboratory in Woods Hole, MA. Michael is a recipient of the Pew Scholars in the Biomedical Sciences award and the McKnight Technology Award.

Prior to becoming CEO of Optimal Acuity Corporation, Michael served as its Chief Science Officer for four years.

He received his PhD in Physics from Harvard University and his BSc in Physics with a Minor in Philosophy from University of California, Berkeley. He was the National Squash Champion in 1994 and the New Jersey State Champion in 2001 and lives in Princeton, NJ.

PhD Berkely; BSc, U-M Ann Arbor
Experience: Allied Chemical, Sunrise
Technologies, Rice University
50+ Years Laser Research

Michael James Berry has been at the forefront of laser research for over 50 years and involved with bringing cutting edge laser  medical devices to market for over 3 decades. He has successfully led the regulatory process for multiple ophthalmic medical devices to achieve approval from the FDA and other regulatory agencies.

Michael Berry is a physical chemist who has discovered chemical lasers and used lasers of all types for chemical, medical, and other applications. His current research interests include vision improvement for patients with age-related macular degeneration and for patients with age-related focus dysfunction (aka presbyopia).

Michael Berry discovered over 100 chemical lasers and used them to understand intimate details of chemical reaction dynamics, such as the distribution of reaction exoergicity into product electronic and vibrational states. He also invented vibrational overtone laser photochemistry, methods for laser isotope separation, photoacoustic Raman spectroscopy, methods and apparatus to correct ocular refractive errors and to improve vision for patients with age-related macular degeneration, methods and apparatus for skin rejuvenation and methods and apparatus for early stage lung cancer detection. He has published over 140 works (peer-reviewed papers, book chapters, etc.) in the scientific, medical, and patent literatures.

Michael Berry is currently the President of Antropix Corporation and the President of Optimal Acuity Corporation. He has previously been the Director of the Corneal Shaping Program at Sunrise Technologies, the Robert A. Welch Professor of Chemistry at Rice University, the Manager of the Photon Chemistry Department at Allied Chemical Corporation (now Honeywell International Inc.), and Assistant, then Associate, Professor of Chemistry at the University of Wisconsin in Madison. He has received a National Science Foundation Fellowship (1969), a Merck Faculty Award, a Camille and Henry Dreyfus Teacher-Scholar Award, an Alfred P. Sloan Fellowship, a John Simon Guggenheim Fellowship, the Phi Lambda Upsilon Fresenius Award, and the American Chemical Society Award in Pure Chemistry.

He is a Fellow of the American Association for the Advancement of Science. Michael received his Bachelor of Science in Chemistry from the University of Michigan in Ann Arbor, MI, and received his PhD in Physical Chemistry degree in 1970 from the University of California, Berkeley. He and his wife Patricia live in Austin, Tx.

MA, Princeton; MPhys, Oxford
Experience: Kearney, Retrosense
Therapeutics, Poopooh LLC, RCCI
10+ Management Experience

Praveena Joseph de Saram has over 15 years of experience in research in Physics and Neuroscience and over 10 years of management experience in the start-up and not-for profit sectors.

Prior to joining OAC, Praveena was Managing Director of the RCCI, a not-for profit supporting people with disabilities and CEO of Poopooh LLC, an innovative triple bottom line pet product manufacturer. Previously, she was a management consultant with AT Kearney and a scientist with the Princeton Neuroscience Institute and Retrosense Therapeutics, a division of Allergan Plc.

Praveena serves on the Board of the Princeton-Blairstown Center and is the Chair of the Board of the Rehabilitation Centre for the Communication Impaired. She also served on the board of the Princeton University Store and the National Steering Committee of Princeton University’s Annual Giving Campaign.

Praveena received her masters in Physics from the University of Oxford and her masters in Molecular Biology and Neuroscience from Princeton University. She lives in Princeton, NJ with her husband, daughter and two dogs.